Candel Therapeutics Inc
NASDAQ:CADL

Watchlist Manager
Candel Therapeutics Inc Logo
Candel Therapeutics Inc
NASDAQ:CADL
Watchlist
Price: 5.94 USD 6.64% Market Closed
Market Cap: 326.1m USD

Operating Margin
Candel Therapeutics Inc

0%
Current
-20 611%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-40.7m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Candel Therapeutics Inc
Glance View

Market Cap
326.1m USD
Industry
Biotechnology

Candel Therapeutics, Inc, formerly Advantagene, Inc, is a clinical stage biopharmaceutical company. The company is headquartered in Needham, Massachusetts and currently employs 50 full-time employees. The company went IPO on 2021-07-27. The firm is focused on helping patients fight cancer with oncolytic viral immunotherapies. Its engineered viruses are designed to induce immunogenic death through viral-mediated cytotoxicity in cancer cells, therefore releasing tumor neo-antigens and creating a pro-inflammatory microenvironment at the site of injection. Its approach combines a knowledge of viral immunotherapy with clinical experience across a range of indications. Its product candidate, CAN-2409 program, is in Phase III clinical trial. Its lead HSV product candidate, CAN-3110, is in Phase I clinical trial. The firm also designs candidates based on its HSV platform for the treatment of solid tumors. The Company’s oncolytic viral immunotherapy platforms is based on genetically modified adenovirus and herpes simplex virus (HSV) constructs. Its preclinical models and clinical trials use its approach.

CADL Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-40.7m
/
Revenue
0
What is the Operating Margin of Candel Therapeutics Inc?

Based on Candel Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top